Sandrock
Alan R. Sandrock, Meadville, PA US
Patent application number | Description | Published |
---|---|---|
20130008389 | CHEW TOY WITH EDIBLE PIECE - An animal toy having two end portions and a shaft releasably connectable between the two end portions has a treat-retaining portion located on the shaft. A method for adjusting a toy for an animal having a muzzle, front teeth and back teeth adjusts the distance between opposing end portions such that during chewing, the treat portion can only come into contact with the front teeth of the animal. | 01-10-2013 |
20130104811 | CHEW TOY WITH EDIBLE PIECE | 05-02-2013 |
20130118417 | CHEW TOY WITH EDIBLE PIECE - An animal toy having two end portions and a shaft releasably connectable between the two end portions has a treat-retaining portion located on the shaft. A method for adjusting a toy for an animal having a muzzle, front teeth and back teeth adjusts the distance between opposing end portions such that during chewing, the treat portion can only come into contact with the front teeth of the animal. | 05-16-2013 |
Alfred Sandrock, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20090202527 | TREATMENT FOR MULTIPLE SCLEROSIS - Methods of treating multiple sclerosis and other disorders are disclosed. | 08-13-2009 |
20120058083 | Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta - The present invention provides methods for the treatment, and pharmaceuticals for the use in the treatment, of mammalian subjects having, or at risk of developing, chronic demyelinating neuropathies, e.g., CIDP. The methods involve the administration of IFN-β therapeutics. | 03-08-2012 |
20140163100 | Methods of Treating Multiple Sclerosis and Preserving and/or Increasing Myelin Content - Methods of treating multiple sclerosis in a subject, including: reducing the frequency of relapse, reducing the annualized relapse rate, reducing the risk of disability progression, reducing the number of new or newly enlarging T2 lesions, reducing the number of gadolinium lesions; and methods of preserving/increasing myelin content in a subject having multiple sclerosis; by daily administering a composition containing a fumarate, such as dimethyl fumarate or monomethyl fumarate, to the subject. | 06-12-2014 |
Karsten Sandrock, Bretten DE
Patent application number | Description | Published |
---|---|---|
20100052886 | System for monitoring the tire pressure in vehicles - Described is a procedure for controlling the transmission operation of a tire pressure monitoring device ( | 03-04-2010 |
20110041596 | Method and System for Monitoring Tire Pressure - The invention relates to a method for monitoring air pressure in vehicle tires using wheel electronics, which comprise a pressure sensor for measuring the air pressure present in the tire, a transmitter for transmitting pressure information, and a receiver for receiving interrogation signals, wherein a transmission activity of the wheel electronics is triggered by the reception of an interrogation signal, which is transmitted as a pulse train comprising a command section that encodes a transmission instruction for the wheel electronics. According to the invention, the pulse train comprises an adjustment section having several pulses before the command section. | 02-24-2011 |
Rainer Sandrock, Kassel DE
Patent application number | Description | Published |
---|---|---|
20100330663 | INCUBATOR COMPRISING A SHAKING DEVICE - An incubator ( | 12-30-2010 |
20140165707 | TEST METHOD AND APPARATUS FOR BIOREACTOR CONTAINERS AND USE - A method for testing the integrity of a bioreactor container includes providing a bioreactor container having a fluid-tight, at least locally flexible wall and having at least one container opening and providing a test apparatus having a bioreactor container compartment and a fluid-permeable and/or structured reception sheet arranged replaceably on the bioreactor container compartment. The method continues by arranging the bioreactor container in the bioreactor container compartment so that the bioreactor container wall contacts the reception sheet in the bioreactor container compartment, connecting the container opening of the bioreactor container to a fluid source filling the bioreactor container with a fluid from the fluid source to generate a predetermined positive pressure Pi in the bioreactor container at a first time Ti and determining whether the bioreactor container is sufficiently leaktight. | 06-19-2014 |
20140193897 | BIOREACTOR CONTAINER AND INTEGRITY CHECK METHOD FOR BIOREACTOR CONTAINERS - A bioreactor container comprising has an at least locally flexible wall and at least one container opening. The wall of the bioreactor container has a fluid-tight inner sheet, and an at least locally fluid-permeable or structured outer sheet. A method for testing the integrity of the bioreactor container also is provided. | 07-10-2014 |
Robert Sandrock, San Carlos, CA US
Patent application number | Description | Published |
---|---|---|
20120230963 | Methods and Compositions for Expanding, Identifying, Characterizing and Enhancing Potency of Mammalian-Derived Glial Restricted Progenitor Cells - Methods for producing a population of human-derived glial restricted progenitor cells (GRPs) with decreased potentially unintended or undesired cellular phenotypes and/or decreased standard deviation in the cells of the population are provided. Also provided are antibody panels and gene expression profiles to characterize GRPs and a method for its use in characterizing GRP cells. In addition methods for use of these GRP cells to generate astrocytes and/or oligodendrocytes, to re-myelinate neurons and to treat glial cell related and other neurodegenerative diseases or disorders or injuries or damage to the nervous system are provided. A method to manufacture neural cells depleted of A2B5 positive cells is also provided. | 09-13-2012 |
Tanya Sandrock, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20120094896 | INHIBITORS OF VIRAL INTEGRASE AND METHODS OF USE - Described herein are compositions and methods for inhibiting HIV integrase activity. Also described are methods of identifying agents that inhibit HIV integrase for use in treating or preventing HIV. Also disclosed are methods of identifying agents that inhibit HIV viral mutants that are resistant to integrase inhibitors. | 04-19-2012 |
20130035255 | CONTROLLED RELEASE HYBRID SYSTEMS - Described herein are controlled release hybrid systems and methods of use thereof. In certain embodiments, the controlled release hybrid systems can be used to screen for interactions between candidate molecules. In addition, these controlled release hybrid systems can be modified to screen for chemical inhibitors of interacting candidate molecules. In another embodiment, the controlled release hybrid systems described herein can be modified to screen for mutant molecules (e.g., peptides, proteins, polypeptides, portions of proteins, portions of polypeptides, or any combination thereof) when compared to candidate molecules that were previously shown to interact. Upon identifying these mutant molecules, the controlled release hybrid systems can be further utilized to identify peptide, chemicals, or a combination thereof that potentially act as inhibitors of these mutant molecules. In this embodiment, the controlled release systems can be readily modified for personalized medication applications. | 02-07-2013 |
20140187477 | INHIBITORS OF VIRAL INTEGRASE AND METHODS OF USE - Described herein are compositions and methods for inhibiting HIV integrase activity. Also described are methods of identifying agents that inhibit HIV integrase for use in treating or preventing HIV. Also disclosed are methods of identifying agents that inhibit HIV viral mutants that are resistant to integrase inhibitors. | 07-03-2014 |
Tanya M. Sandrock, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20090035754 | Methods and compositions for detecting steroids - The present invention provides for methods and systems for detecting steroids. Examples of such steroids include estrogen, progesterone, androgen, testosterone, and derivatives and analogs thereof. Systems useful for carrying out the method include tripartite constructs including a DNA-binding domain, a ligand binding domain, and an activation domain. The present invention provides numerous improvements over previous diagnostic systems for detection of steroids, such advantages include that the method allows for detection of steroid analogs and derivatives, whose structures may not yet be known, the method is generally applicable to a wide variety of organisms, and numerous ligand binding domains may be used in conjunction with the present system. | 02-05-2009 |
20110086778 | ENHANCED MICROPLATE CONFIGURATIONS - An enhanced microplate can include a base having a footprint with a length of 5 127.76 mm±1 mm and a width of 85.48 mm±1 mm. The base can be configured for an array of microwells having a base being configured for an array of micro wells such that there are ax rows along the width and ∥bx∥ columns along the length, where a is 8 or 9, b is 12, 13 or 14 provided that when b is 12, a is 9, and x is 0.5 or a positive integer. These enhanced microplates can be used to effectively increase throughput, decrease analysis time, and can be readily integrated into existing systems. | 04-14-2011 |
20110152128 | ENHANCED MICROPLATE CONFIGURATIONS - An enhanced microplate and retention device for selectively retaining tube inserts within the microplate. A dynamic microplate having a selectable number of interchangeable microwells. | 06-23-2011 |
Thomas Sandrock, Bonn DE
Patent application number | Description | Published |
---|---|---|
20100179523 | Urological Diode Laser Systems having a Glass-Fiber Application System - The invention relates to a system for medicinal treatment, in particular for treating benign prostatic hyperplasia BPH, for use in the event of tumor resection or for use in thoracic surgery. The system comprises a diode laser device for producing a laser beam and to an application system based on optical wave guides that can be endoscopically introduced into a patient. Said system is designed in such a manner that the laser beam, produced by the diode laser device is guided through the application system and is emitted by said application system so that biological tissue can be treated in a selective manner with the emerging laser beam. | 07-15-2010 |